Background
==========

Valid data on morbidity, at the regional level, is essential for planning of primary healthcare services that are specifically tailored to the needs, demands and requirements of the local population. The currently available peer reviewed literature indicates multiple avenues of population health surveillance including national surveys, administrative data and electronic health records. National surveys are surveillance methods that have commonly been used \[[@B1],[@B2]\], but that demonstrate multiple shortcomings. Prevalence estimates obtained from national and state level surveys are based on self-reported measures, provided by respondents of these surveys, the accuracy of which is questionable \[[@B2]\]. Secondly, surveys do not include all aspects of health, and therefore do not provide a full and accurate picture of health \[[@B3]\], resulting in a lack of generalisability to smaller regional populations \[[@B4]\]. Additionally, different subgroups of the population may demonstrate different response rates to surveys, which impacts on the generalisability of the survey data to the general population \[[@B5],[@B6]\]. Surveys, however, provide prevalence rates comparable to routinely collected clinical administrative data \[[@B1]-[@B3]\], indicating that clinical administrative data is a potential avenue for surveillance. The use of information obtained from administrative data, including primary care medical records (data collected during general practitioner (GP) visits), physician billing, specialist visits, pharmacy data (prescription dispensation) and hospital data (inpatient/outpatient information); has been shown to provide reliable and valid prevalence estimates of chronic disease conditions \[[@B1]-[@B3],[@B7],[@B8]\].

Clinical administrative data is widely available \[[@B1]\] and its collection and reporting systems are currently in place in both primary care and tertiary levels of care \[[@B9]\]. Further, administrative data is validated by the clinical judgment of medical practitioners and may be generalisable to smaller/regional populations \[[@B10]\]. Patient data that is entered into electronic medical recording software at the point of contact with primary health care practitioners is often supported by diagnostic testing and clinical examination, and is thus likely to be more valid than self-reported health information \[[@B10]\]. The peer-reviewed literature hence provides a vast amount of current evidence on the effectiveness of utilising administrative and/or primary care data for population health surveillance; however, there exists a current lack of such data based disease monitoring models in Australia.

The Sentinel Practices Data Sourcing (SPDS) project aimed to implement a sentinel site surveillance system within the Illawarra-Shoalhaven region of the state of New South Wales (NSW) in Australia to obtain a region-specific prevalence of chronic diseases and mental health disorders through the use of patient data obtained during primary care patient interactions. A pre-tested method of data extraction \[[@B10]\] was used, aimed at informing the population health planning within health service catchments of regional Australia.

Methods
=======

The study was conducted in the Illawarra-Shoalhaven region of the state of NSW in Australia (Figure [1](#F1){ref-type="fig"}). Within NSW there are 15 Local Health Districts which are responsible for the acute, sub-acute and tertiary care service delivery in the state through the public hospital system; and 17 Medicare Locals which are responsible for the primary healthcare planning and delivery for their constituent regions \[[@B10]\]. Unlike other regions, the geographical catchment boundary of the Illawarra-Shoalhaven Local Health District (ISLHD) is the same as that covered by a single Medicare Local namely the Illawarra-Shoalhaven Medicare Local (ISML); which places the region in a unique and advantageous position in terms of planning and implementing a chronic disease surveillance system. Additionally the region has a diverse socio-economic profile and has pockets of both higher and lower socio-economic disadvantage, comparing the Index of Relative Socio-Economic Disadvantage (IRSD) scores between the region and for Australia as a whole (Figure [2](#F2){ref-type="fig"}). IRSD is a composite summary measure constructed by the Australian Bureau of Statistics (ABS) for all regions in Australia and is a based on income, educational attainment, employment status, occupation type, family structure, dwellings, house ownership, marital status and ethnicity \[[@B11]\].

![Illawarra-Shoalhaven region of NSW and its Statistical Local Areas (SLAs) on the map of Australia.](1471-2458-14-557-1){#F1}

![**Socioeconomic snapshot of the Illawarra-Shoalhaven region: Index of Relative Socio-Economic Disadvantage (IRSD) scores compared with NSW state and Australian national averages.** \*Illawarra-Shoalhaven score is a population weighted average of individual SLA scores.](1471-2458-14-557-2){#F2}

The study undertook secondary analysis of administrative data through extraction of de-identified clinical patient information and the project was rolled out in 4 phases: -

Phase 1: Practice recruitment
-----------------------------

The study aimed to recruit 12--18 practices within the Illawarra-Shoalhaven region based on the Statistical Local Area (SLA) geography and the demographic profile of the catchment. Eligible practices were identified by requesting the Illawarra-Shoalhaven Medicare Local (ISML) for a list of the region's practices that fulfilled the following inclusion criteria (n = 52):

✓ location in one of the 7 SLAs that represent the Illawarra-Shoalhaven region;

✓ multiple (more than 1) GPs working at the practice site (solo practitioner sites are likely to have smaller patient numbers);

✓ employment of either more than one full-time GP or more than two part-time GPs (i.e. who work for at least 20 hours a week);

✓ additional criteria: -

• installation of a clinical auditing software package on desktop software or a desire to install and use the Pen Computer Systems (PCS) Clinical Audit Tool: ™(PCS CAT) (multiple licensing for PCS CAT has been procured by ISML and is therefore freely available to all general practices within its catchment); and

• a willingness to provide de-identified practice data extracts to the researchers for surveillance purposes.

Seventeen general practices in the catchment volunteered and consented to participate in the study (response rate = 33%). Only two electronic medical record software packages were being used by participating practices in the study, either Medical Director™ (n = 8) or Best Practice™ (n = 9).

Phase 2: Data cleansing and enhancement of data accuracy
--------------------------------------------------------

Recruited practices undertook comprehensive "Data Cleansing" training to understand the usage and the various functionalities of PCS CAT, and to update and clean the data stored in their clinical systems. With the consent of the primary GPs and managers within each practice, the "Data Cleansing" training was conducted by the researchers. The cleaning of practice records improves searches (in both the practice electronic medical record software program and the PCS CAT), to identify patients with particular conditions and thus to target health research and patient management activities. This data cleaning process allowed the complete patient database that had been entered during GP consultations to be identified when searching for specific variables. The data cleansing phase of the study was conducted using the data maintenance utility tools which are available within both the GP electronic medical record software programs used in the study. Data cleansing included: -

• encouraging all practice staff to use the 'drop down box functionality' of their clinical software to define and code all medical diagnoses and other sections of the patient record;

• strictly avoiding free text entries in all sections of the patient record;

• finding all identifiable free text non-coded past medical history items, and either linking them to appropriate coded items or replacing them with the correct coded item; and

• coding all inactive patients as 'Inactive' (an 'active patient' is one who has attended the practice three or more times in the past two years as defined in the Royal Australian College of General Practice: Standards for general practices \[[@B12]\]).

Phase 3: Data collection
------------------------

Patient data that had been de-identified by practice employees was extracted to a database. Data items extracted from general practice clinical systems included: demography (population by age and sex and population geography including postcodes and suburbs), chronic disease surveillance items (hypertension, type 2 diabetes mellitus, depression, anxiety, COPD, asthma, congestive heart disease, stroke, osteoarthritis, osteoporosis, high Body Mass Index (BMI) -- overweight and obese), and Medicare Benefits Schedule (MBS) items uptake relevant to primary care services for GP and other non-referred attendances. A cleaned, de-identified PCS CAT data extract was performed in September 2013 for all recruited practices which included all information obtained from patient interactions in the preceding 24 months for all diagnosed pathologies, clinical variables such as anthropometric measures, and patient demographic information such as age, sex, geographical location of residence (postcodes and suburbs) and indigenous status.

Phase 4: Data collation and analysis
------------------------------------

The research team collated all extracted data, cross-matched residential suburb and postcode information with health and clinical information using de-identified unique link ID tags, converted all resultant information into usable database formats, and then analysed the datasets using Microsoft Excel (V2007: Microsoft Corporation, Redmond Washington, USA). The final datasets hence included clinical diagnosis and patient demographic information as entered by GPs within each participating practice. Basic epidemiological measures, including age-specific prevalence and total prevalence were calculated for all major disease conditions. The prevalence figures were compared against comparable indicators reported for the same age groups by the Australian Health Survey (AHS) 2011--12 conducted by the ABS \[[@B13]\].

The age-specific disease prevalence figures obtained from the study sample and the estimated national prevalence figures reported by the AHS 2011--12 were then age-standardised using the 2011 estimated resident population of Australia \[[@B14]\]. Comparisons across age-standardised prevalence were conducted for all major chronic conditions that the SPDS project is targeting for regular surveillance namely; obesity, overweight, diabetes mellitus, hypertension, asthma, mental health disorders such as clinically diagnosed depression and anxiety disorder, coronary heart disease, stroke, and chronic bone diseases such as osteoarthritis and osteoporosis. Both Microsoft Excel (V2007: Microsoft Corporation, Redmond Washington, USA) and the PCS CAT tool (v.3.1: pencs.com.au) were used for graphical illustration of demographic data and age-specific disease prevalence.

The study undertook secondary analysis of administrative data through extraction of de-identified clinical patient information. The study was performed with the approval of the Human Research Ethics Committee (Health and Medical) of the University of Wollongong (HE 12/447). Written informed consent was not obtained from individual patients due to the retrospective nature of the study design, however all data was exclusively extracted and de-identified by trained practice clinical staff only.

Results
=======

The number of patients that had visited the 17 general practices within the previous 24 months (September 2011 to September 2013) was 164,435 (152,767 from within the Illawarra-Shoalhaven and 11,668 from outside of the catchment). The Illawarra-Shoalhaven catchment sample of 152,767 included 70,103 men, 82,506 women and 158 without an identified gender.

While 144 patients did not have their age recorded, the median age for the study sample (n = 152,767) was 39 years (IQR = 20 -- 58 years). Adults aged 20--24 years comprised the largest age group at 7% of the total sample, followed by the 40--44 year old age group (6.8%), and 5--9 year old children (6.6%). Older adults aged 65 years and above comprised 18.2% of the sample. The population pyramid of the study sample along with the comparison with the population structure of the 2011 estimated resident population of the Illawarra-Shoalhaven catchment is shown in Figure [3](#F3){ref-type="fig"}. The proportion of the local residential population of the SLAs that consulted the study practices during the study period is shown in Table [1](#T1){ref-type="table"}\[[@B14]\]. The majority of the study sample (92.9%) were found to reside within the Illawarra-Shoalhaven catchment SLAs.

![Population pyramid comparisons: study sample and the 2011 resident population of the Illawarra-Shoalhaven catchment.](1471-2458-14-557-3){#F3}

###### 

Proportion of local population that had consulted the 17 general practices during the previous 24 months (September 2011 to September 2013)

  **Illawarra-Shoalhaven SLAs**   **No. of patients from the SLA within the sample**   **Proportion of the sample from the SLA (%)**   **Estimated Resident Population of the SLA, 2011\***   **Proportion of the SLA population included in the sample (%)**
  ------------------------------- ---------------------------------------------------- ----------------------------------------------- ------------------------------------------------------ -----------------------------------------------------------------
  Jervis Bay Territory            6                                                    0.0                                             387                                                    1.6
  Kiama (A)                       19769                                                12.9                                            20832                                                  94.9
  Shellharbour (C)                44971                                                29.4                                            66054                                                  68.1
  Shoalhaven (C) - Pt A           15347                                                10.0                                            34444                                                  44.6
  Shoalhaven (C) - Pt B           26000                                                17.0                                            61599                                                  42.2
  Wollongong (C) - Inner          23351                                                15.3                                            104601                                                 22.3
  Wollongong (C) Bal              23323                                                15.3                                            96614                                                  24.1
  **Total**^**\^**^               **152767**                                           **100**                                         **384531**                                             **39.7**

\*ABS \[[@B14]\].

^\^^Total number of patients in the data extract = 164,435; n = 152,767 after excluding patients residing outside the Illawarra-Shoalhaven SLAs and removing patients with geographic data inaccuracies.

The age-specific population and disease counts within the study sample for major chronic conditions and high BMI are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"} respectively, while the crude and age-standardised prevalence comparisons of the sample and the Australian national estimates \[[@B13]\] are shown in Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} respectively. Overall the study sample population exhibits figures higher than Australian averages for the age-standardised prevalence of chronic conditions such as anxiety, cancer, hypertension, obesity and overweight/obesity (Figure [4](#F4){ref-type="fig"}). An illustration of age-specific burden of disease (Figure [5](#F5){ref-type="fig"}) indicates that prevalence (non-age standardised) of asthma and mental health conditions (depression and anxiety) are significantly higher amongst younger age groups compared to older adults.

###### 

Age-specific population and chronic disease counts within the study sample during the last 24 months (September 2011 to September 2013)

  **SLA**                  **Age**      **Denominator (n)**   **Type 2 Diabetes**   **CHD**    **Stroke**   **Asthma**   **COPD**    **Osteoarthritis**   **Osteoporosis**   **Depression**   **Anxiety**   **Cancer**   **Hypertension**
  ------------------------ ------------ --------------------- --------------------- ---------- ------------ ------------ ----------- -------------------- ------------------ ---------------- ------------- ------------ ------------------
  Jervis Bay Territory     0-14         3                     0                     0          0            0            0           0                    0                  0                0             0            0
  15-24                    0            0                     0                     0          0            0            0           0                    0                  0                0             0            
  25-34                    0            0                     0                     0          0            0            0           0                    0                  0                0             0            
  35-44                    2            0                     0                     0          0            0            0           0                    0                  0                0             0            
  45-54                    0            0                     0                     0          0            0            0           0                    0                  0                0             0            
  55-64                    1            0                     1                     0          0            0            0           0                    0                  0                0             0            
  65-74                    0            0                     0                     0          0            0            0           0                    0                  0                0             0            
  75 & Above               0            0                     0                     0          0            0            0           0                    0                  0                0             0            
  **Total**^**\^**^        **6**        **0**                 **1**                 **0**      **0**        **0**        **0**       **0**                **0**              **0**            **0**         **0**        
  Kiama (A)                0-14         3348                  0                     0          0            262          0           0                    0                  6                20            1            0
  15-24                    2572         1                     0                     1          190          0            0           2                    118                57               1             5            
  25-34                    2138         0                     0                     2          137          1            4           1                    115                80               3             13           
  35-44                    2450         12                    5                     6          147          4            30          3                    191                94               8             115          
  45-54                    2558         39                    18                    15         143          13           96          19                   218                104              24            286          
  55-64                    2751         124                   100                   26         180          29           267         80                   227                113              59            691          
  65-74                    2094         203                   152                   53         134          72           355         145                  152                71               128           844          
  75 & Above               1844         209                   284                   126        137          132          437         329                  147                63               122           980          
  **Total**^**\^**^        **19755**    **588**               **559**               **229**    **1330**     **251**      **1189**    **579**              **1174**           **602**          **346**       **2934**     
  Shellharbour (C)         0-14         9359                  0                     1          1            1028         1           1                    0                  31               64            2            5
  15-24                    6826         0                     0                     1          598          1            7           2                    483                334              3             19           
  25-34                    6381         10                    4                     4          543          8            39          4                    714                478              5             55           
  35-44                    6191         33                    15                    13         530          33           131         6                    816                511              16            245          
  45-54                    5378         106                   64                    32         490          85           336         34                   767                434              26            627          
  55-64                    4340         168                   158                   50         456          161          629         126                  598                323              68            1055         
  65-74                    3328         254                   329                   99         338          233          841         236                  447                298              94            1276         
  75 & Above               3156         302                   638                   215        343          405          1146        575                  567                256              117           1504         
  **Total**^**\^**^        **44959**    **873**               **1209**              **415**    **4326**     **927**      **3130**    **983**              **4423**           **2698**         **331**       **4786**     
  Shoalhaven (C) - Pt A    0-14         2865                  0                     0          0            236          0           0                    0                  1                16            0            0
  15-24                    2027         1                     0                     2          271          0            0           1                    133                85               1             3            
  25-34                    1774         9                     0                     2          172          0            3           3                    178                101              1             27           
  35-44                    1794         18                    3                     5          159          5            26          4                    267                138              10            97           
  45-54                    1930         84                    32                    23         169          29           94          19                   280                102              19            310          
  55-64                    1928         190                   108                   39         194          56           269         62                   261                93               50            642          
  65-74                    1554         265                   167                   68         147          104          394         128                  200                99               108           760          
  75 & Above               1457         238                   318                   153        139          140          541         286                  167                109              106           863          
  **Total**^**\^**^        **15329**    **805**               **628**               **292**    **1487**     **334**      **1327**    **503**              **1487**           **743**          **295**       **2702**     
  Shoalhaven (C) - Pt B    0-14         4344                  0                     0          0            307          3           0                    2                  5                15            0            2
  15-24                    2970         0                     0                     0          302          0            0           0                    129                86               2             4            
  25-34                    2486         3                     1                     0          188          2            5           3                    249                94               10            39           
  35-44                    3032         26                    7                     5          186          1            44          5                    366                163              18            119          
  45-54                    3486         78                    45                    20         201          29           178         27                   410                173              72            429          
  55-64                    3767         222                   134                   28         191          81           430         110                  403                168              171           921          
  65-74                    3297         403                   323                   86         221          149          736         200                  299                152              291           1414         
  75 & Above               2576         356                   418                   133        164          160          786         314                  238                107              351           1292         
  **Total**^**\^**^        **25958**    **1088**              **928**               **272**    **1760**     **425**      **2179**    **661**              **2099**           **958**          **915**       **4220**     
  Wollongong (C) - Inner   0-14         3914                  0                     0          3            339          1           0                    0                  3                14            3            1
  15-24                    2926         2                     0                     1          221          1            0           1                    125                123              2             2            
  25-34                    3095         4                     0                     2          205          1            2           2                    202                158              0             39           
  35-44                    3305         29                    9                     4          180          9            26          9                    307                200              20            100          
  45-54                    3070         79                    28                    12         184          26           99          43                   316                203              52            344          
  55-64                    2713         158                   119                   21         179          53           281         141                  253                189              98            638          
  65-74                    2082         267                   199                   55         138          95           376         216                  196                134              145           790          
  75 & Above               2203         362                   403                   136        157          173          614         454                  169                115              230           1186         
  **Total**^**\^**^        **23308**    **901**               **758**               **234**    **1603**     **359**      **1398**    **866**              **1571**           **1136**         **550**       **3100**     
  Wollongong (C) Bal       0-14         4411                  0                     0          1            370          9           2                    0                  6                24            0            0
  15-24                    3141         1                     1                     3          270          17           4           0                    193                167              2             11           
  25-34                    3121         6                     0                     6          236          13           7           5                    379                269              4             33           
  35-44                    3080         23                    13                    7          208          35           47          7                    461                311              12            174          
  45-54                    2850         96                    49                    18         186          86           162         28                   402                263              40            440          
  55-64                    2489         199                   143                   43         161          137          380         105                  319                209              78            780          
  65-74                    2036         236                   216                   89         134          229          538         177                  210                156              129           888          
  75 & Above               2180         290                   420                   189        127          284          729         403                  254                150              207           1173         
  **Total**^**\^**^        **23308**    **851**               **842**               **356**    **1692**     **810**      **1869**    **725**              **2224**           **1549**         **472**       **3499**     
  Entire Sample            0-14         28244                 0                     1          5            2542         14          3                    2                  52               153           6            8
  15-24                    20462        5                     1                     8          1852         19           11          6                    1181               852              11            44           
  25-34                    18995        32                    5                     16         1481         25           60          18                   1837               1180             23            206          
  35-44                    19854        141                   52                    40         1410         87           304         34                   2408               1417             84            850          
  45-54                    19272        482                   236                   120        1373         268          965         170                  2393               1279             233           2436         
  55-64                    17989        1061                  763                   207        1361         517          2256        624                  2061               1095             524           4727         
  65-74                    14391        1628                  1386                  450        1112         882          3240        1102                 1504               910              895           5972         
  75 & Above               13416        1757                  2481                  952        1067         1294         4253        2361                 1542               800              1133          6998         
  **Total**^**\^**^        **152623**   **5106**              **4925**              **1798**   **12198**    **3106**     **11092**   **4317**             **12978**          **7686**         **2909**      **21241**    

^\^^n = 152,767 but 144 patients without a recorded age were excluded, leaving n = 152,623 patients. All region stratified totals also exclude patients without a recorded age.

###### 

Age-specific population and high BMI counts within the study sample during the last 24 months (September 2011 to September 2013)

  **SLA\~**                **Age**              **Quantified BMI\*: Denominator (n) \[proportion of sample population (%)\]**   **Obese**   **Overweight/obese**
  ------------------------ -------------------- ------------------------------------------------------------------------------- ----------- ----------------------
  Kiama (A)                18-24                367 \[19.7\]                                                                    42          101
  25-34                    366 \[17.1\]         75                                                                              178         
  35-44                    513 \[20.9\]         164                                                                             336         
  45-54                    782 \[30.6\]         283                                                                             557         
  55-64                    979 \[35.6\]         372                                                                             782         
  65-74                    958 \[45.7\]         354                                                                             726         
  75 & Above               1125 \[61\]          275                                                                             735         
  **Total**^**\^**^        **5090 \[32.4\]**    **1565**                                                                        **3415**    
  Shellharbour (C)         18-24                510 \[10.4\]                                                                    132         257
  25-34                    754 \[11.8\]         277                                                                             465         
  35-44                    778 \[12.6\]         366                                                                             602         
  45-54                    983 \[18.3\]         445                                                                             779         
  55-64                    832 \[19.2\]         367                                                                             689         
  65-74                    744 \[22.4\]         333                                                                             610         
  75 & Above               775 \[24.6\]         228                                                                             524         
  **Total**^**\^**^        **5376 \[16.0\]**    **2148**                                                                        **3926**    
  Shoalhaven (C) - Pt A    18-24                528 \[37.5\]                                                                    90          187
  25-34                    596 \[33.6\]         200                                                                             345         
  35-44                    696 \[38.8\]         277                                                                             507         
  45-54                    987 \[51.1\]         417                                                                             751         
  55-64                    1119 \[58\]          470                                                                             892         
  65-74                    993 \[63.9\]         417                                                                             798         
  75 & Above               1004 \[68.9\]        261                                                                             676         
  **Total**^**\^**^        **5923 \[50.0\]**    **2132**                                                                        **4156**    
  Shoalhaven (C) - Pt B    18-24                468 \[21.9\]                                                                    55          135
  25-34                    524 \[21.1\]         147                                                                             296         
  35-44                    823 \[27.1\]         252                                                                             541         
  45-54                    1258 \[36.1\]        414                                                                             889         
  55-64                    1492 \[39.6\]        517                                                                             1102        
  65-74                    1641 \[49.8\]        625                                                                             1290        
  75 & Above               1481 \[57.5\]        376                                                                             990         
  **Total**^**\^**^        **7687 \[37.0\]**    **2386**                                                                        **5243**    
  Wollongong (C) - Inner   18-24                583 \[26.1\]                                                                    73          167
  25-34                    729 \[23.6\]         161                                                                             355         
  35-44                    1048 \[31.7\]        295                                                                             681         
  45-54                    1179 \[38.4\]        414                                                                             846         
  55-64                    1042 \[38.4\]        372                                                                             782         
  65-74                    870 \[41.8\]         355                                                                             688         
  75 & Above               1138 \[51.7\]        322                                                                             746         
  **Total**^**\^**^        **6589 \[35.2\]**    **1992**                                                                        **4265**    
  Wollongong (C) Bal       18-24                441 \[19.1\]                                                                    87          181
  25-34                    634 \[20.3\]         252                                                                             422         
  35-44                    812 \[26.4\]         373                                                                             622         
  45-54                    1099 \[38.6\]        476                                                                             850         
  55-64                    970 \[39\]           467                                                                             804         
  65-74                    891 \[43.8\]         424                                                                             714         
  75 & Above               1195 \[54.8\]        350                                                                             811         
  **Total**^**\^**^        **6042 \[33.4\]**    **2429**                                                                        **4404**    
  Entire sample            18-24                2897 \[19.5\]                                                                   479         1028
  25-34                    3603 \[19\]          1112                                                                            2061        
  35-44                    4670 \[23.5\]        1727                                                                            3289        
  45-54                    6288 \[32.6\]        2449                                                                            4672        
  55-64                    6434 \[35.8\]        2565                                                                            5051        
  65-74                    6097 \[42.4\]        2508                                                                            4826        
  75 & Above               6718 \[50.1\]        1812                                                                            4482        
  **Total**^**\^**^        **36707 \[30.9\]**   **12652**                                                                       **25409**   

\*Only includes patients with both height and weight recorded.

 \~ No patients identified in Jervis Bay Territory for this indicator.

^\^^All region stratified totals also exclude patients without a recorded age.

###### 

Crude prevalence proportions of chronic conditions in the study sample compared to Australian national averages

  **Chronic Disease/Conditions (as defined and entered into electronic records by GP)**   **Crude prevalence in sample (%) (95% CI)**   **Australian crude disease prevalence (AHS 2011--12\~) (%) (95% CI)**
  --------------------------------------------------------------------------------------- --------------------------------------------- -----------------------------------------------------------------------
  Type 2 Diabetes                                                                         3.3 (3.26 - 3.44)                             3.4 (3.09 - 3.71)
  CHD                                                                                     3.2 (3.14 - 3.32)                             4.7 (4.39 - 5.01)
  Stroke                                                                                  **1.2 (1.12 - 1.23)**                         1.1 (0.94 - 1.26)
  Asthma                                                                                  8.0 (7.86 - 8.13)                             10.2 (9.58 - 10.82)
  COPD                                                                                    2.0 (1.96 - 2.11)                             2.4 (2.09 - 2.71)
  Osteoarthritis                                                                          7.3 (7.14 - 7.4)                              8.3 (7.84 - 8.76)
  Osteoporosis                                                                            2.8 (2.75 - 2.91)                             3.3 (3.03 - 3.57)
  Depression                                                                              8.5 (8.36 - 8.64)                             9.7 (9.19 - 10.21)
  Anxiety                                                                                 **5.0 (4.93 - 5.15)**                         3.8 (3.45 - 4.15)
  Cancer                                                                                  **1.9 (1.84 - 1.97)**                         1.5 (1.29 - 1.71)
  Hypertension                                                                            **13.9 (13.74 - 14.09)**                      10.2 (9.72 - 10.68)
  Obesity (BMI ≥ 30)\*                                                                    **34.5 (33.98 - 34.95)**                      28.3 (27.36 - 29.24)
  Overweight or obese (BMI ≥ 25)\*                                                        **69.2 (68.75 - 69.69)**                      63.4 (62.28 - 64.52)

\*Adults Only.

\~ABS \[[@B13]\].

Bold font indicates a higher prevalence than national estimates in the study sample.

###### 

Age-standardised prevalence of chronic conditions in the study sample compared to Australian national averages

  **Chronic Disease/Conditions (as defined and entered into electronic records by GP)**   **Age-standardised disease prevalence in sample (%)**   **Australian age-standardised disease prevalence (AHS 2011--12\~) (%)**
  --------------------------------------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------------------------
  Type 2 Diabetes                                                                         2.8                                                     3.4
  CHD                                                                                     2.6                                                     4.9
  Stroke                                                                                  0.9                                                     1.1
  Asthma                                                                                  8.0                                                     10.2
  COPD                                                                                    1.7                                                     2.4
  Osteoarthritis                                                                          6.1                                                     8.4
  Osteoporosis                                                                            2.2                                                     3.4
  Depression                                                                              8.4                                                     9.7
  Anxiety                                                                                 **5.0**                                                 3.8
  Cancer                                                                                  **1.6**                                                 1.5
  Hypertension                                                                            **11.9**                                                10.4
  Obesity (BMI ≥ 30)\*                                                                    **33.6**                                                28.3
  Overweight or obese (BMI ≥ 25)\*                                                        **65.9**                                                63.4

\*Adults Only.

\~ABS \[[@B13]\].

Bold font indicates a higher prevalence than national estimates in the study sample.

![**Comparisons of age-standardised chronic disease prevalence between the study sample and Australian national averages.** \*Includes adults only.](1471-2458-14-557-4){#F4}

![Age-specific prevalence of chronic diseases within the study sample.](1471-2458-14-557-5){#F5}

Discussion
==========

In Australia, nationally representative data is available through the National Health Surveys (NHS) conducted by the Australian Bureau of Statistics (ABS) \[[@B15]\] and regionally through state surveys such as the annual New South Wales Population Health Survey \[[@B16]\]; however, extrapolations of these data to smaller geographical areas such as Local Government Areas (LGAs) and/or small area geographic regions within LGAs such as SLAs and suburbs is limited \[[@B10]\].

In 2011--12, the percentage of adults who saw a GP in the preceding 12 months varied across Australia ranging from 74% to 86%, with the Illawarra-Shoalhaven catchment recording the highest percentage nationally \[[@B17]\]. This indicates that extraction of patient and GP interactions over a 24 month period has the potential to include health information of almost the entire resident population of catchment regions such as the Illawarra-Shoalhaven; however, not all SLAs were evenly represented in terms of coverage in this study.

All general practice clinical and electronic medical record softwares utilise one of the several nationally validated health coding and medical classification systems such as SNOMED-CT, DOCLE, PYEFINCH and ICPC2+ \[[@B10]\]. These medical vocabularies enable recording of nationally/internationally recognised coded disease diagnosis, which also assists in maintaining accurate and consistent primary care clinical data that can be extracted and analysed \[[@B10]\]. Additionally, recent introduction of the Personally Controlled Electronic Health Records (PCEHR) in Australia, further requires general practices to "*work towards recording the majority of diagnoses for active patients electronically*" \[[@B18]\]. This enables accurate recording and easy identification of medical conditions and hence provides an opportunity for successful public health and chronic disease surveillance. However, Aizpuru et al. \[[@B19]\] suggest that chronic disease data from electronic health records provide a lower prevalence of conditions, as compared to health surveys because actions taken by physicians are often not recorded leading to cases being missed out. The limitations of primary care practice based data collection have also been illustrated in systematic reviews. Common problems include inconsistent diagnostic coding vocabulary of different clinical systems \[[@B20]\] and errors in data entry and recording \[[@B7],[@B21]\]. Major barriers faced by general practice staff in this regard include difficulties with clinical coding of diagnoses; complexities with software applications; preference for entering free text rather than the pre-coded options; inadequate skills in information technology; time constraints; poor motivation and low prioritisation of data entry compared to other clinical duties; inconsistency of data entry; coding of a condition in order to justify choice of prescribed treatment; and the additional burden of including laboratory test results in patient records, as well as a need to enter a diagnosis, even in the early preclinical stages of the disease (Attard E, Ghosh A, Charlton K: Barriers faced by general practice staff in maintaining clean primary care databases: a systematic review, unpublished).

Studies conducted in Canada \[[@B22],[@B23]\], Italy \[[@B24]\] and the UK \[[@B25]\] have demonstrated methods to improve the quality and accuracy of practice-based disease surveillance models. Keshavjee et al. \[[@B22]\] trained and employed 'data managers' in an attempt to standardise disease coding and de-identify patient information. Similarly, Griever et al. \[[@B23]\] employed a trained data entry clerk to check missing or incorrectly coded records. Cricelli et al. \[[@B24]\] trained GPs, themselves, in data entry and use of standard software. Pearson et al. \[[@B25]\] provided initial training and updates to all doctors and practice staff and carried out validation procedures such as verification of clinical coding, checking for rare diagnoses and those made outside the usual age and sex parameters through random validation visits to all participating practices.

A number of limitations to the study need consideration. The SPDS study identified various common data entry errors, including misspelt suburb names or postcodes that did not match the suburb entry, missing geographic information (postcodes and suburbs), missing values for age and sex, incorrect/mismatched entries within data entry fields such as height inserted in the weight field and/or vice-versa, and missing entries for weight and/or height measurements. While geospatial analysis of disease patterns is highly useful to target services towards areas of need \[[@B26]\], the SPDS data has highlighted difficulties in obtaining consistent information on patient residential postcodes and suburbs, including missing entries and mismatched entries, for example, a record with suburb of the Kiama (A) SLA and postcode of 3000 which is the incorrect postcode for this suburb. It was often unclear which variable to change in order to resolve this inconsistency and hence led to the deletion of such records from the analysis. Data quality and accuracy discrepancies required immense post-extraction data cleaning/editing efforts by the researchers which is vital to improve data linkage quality \[[@B27]\]. It is therefore imperative to undertake further research and technological innovation into improving utility and interface functionality of practice clinical desktop systems and creation of valid and easy to use advanced data aggregation systems which could vastly improve the processes of primary care clinical data extraction and modelling resulting in furthermore accurate prevalence estimation.

Both international literature and Australian evidence identifies a higher reported prevalence of overweight and/or obesity within primary care settings \[[@B28],[@B29]\]. It has been argued that obese patients are more likely than healthy or underweight patients to visit their physician and also more likely to be weighed and measured by practice staff and clinicians. This results in lower population denominators for obesity and overweight, as also seen in our study (Table [3](#T3){ref-type="table"}), and arguably higher prevalence figures. This is another limitation of the proposed method of surveillance.

The seventeen general practices recruited from the major SLAs within the Illawarra-Shoalhaven region include approximately 40% of the resident population of the catchment area but generalisability of the findings to the general population of the Illawarra-Shoalhaven region cannot be assumed. Additionally there was a clear coverage disparity between the 7 Illawarra-Shoalhaven SLAs with high representation of Kiama (A) and Shellharbour (C) residents, moderate representation of the Shoalhaven (C) - Pt A and Shoalhaven (C) - Pt B residents and low proportional share of Wollongong (C) Inner and Wollongong (C) Bal SLAs within the study sample (Table [1](#T1){ref-type="table"}). This can be attributed to the recruitment of practices that voluntarily consented to participate rather than routine surveillance as such. Thus, disease prevalence estimates drawn from the study sample may not be representative of the true population disease status for the region.

Another limitation to the study is that it only investigated the interaction between one extraction tool (the PCS CAT) and two general practice electronic medical record (EMR) software systems (Best Practice™ and Medical Director™). Although these are the most commonly used systems in Australia, the findings cannot be extrapolated to other systems. Additionally the validity of a PCS CAT extract has not been completely investigated. While the tool is co-developed by the Royal Australian College of General Practice (RACGP), the peak body of general practice in Australia and is advocated by them as an integrated product aimed at improving the way patient information can be used to better inform decisions in both clinical and business settings \[[@B30]\]; to date there has not been any empirical validation of the PCS CAT as a general practice data extraction tool. Further research into validation of the PCS CAT extract and the assessment of its agreement with manual data review/audit is required. A final limitation is that we only included data that could potentially be extracted from the electronic medical record software programs. While the data cleansing phase of the study focused heavily on avoidance of any free text entered into medical or clinical notes by GPs and practice staff; if a practitioner still made free text entries rather than using the codable sections of the record, then neither the extraction tool nor our manual case record reviews/audits would be able to detect those cases.

Despite these limitations the SPDS study has significant implications for public health planning, primary health care delivery and epidemiological research. Apart from ongoing chronic disease surveillance, the study methodology and protocol also has the potential to provide evidence-based direction to population health planning strategies aimed at addressing the local health needs of regional areas of Australia. The most recently reported planning documents for the Illawarra-Shoalhaven region of NSW, both from the Local Health District level \[[@B31]\] and the Medicare Local level \[[@B32]\], illustrate disease rates and health status indicators drawn from statistically modelled estimates from the 2006--07 Australian National Health Surveys. These figures are significantly outdated for planning purposes in 2014 and their generalisability for regional and smaller area disease prevalence and health status is questionable \[[@B10]\]. The proposed surveillance system also provides opportunity for monitoring trends in chronic disease prevalence across regular time intervals and promotes the engagement of general practice staff and clinicians in maintaining primary care clinical data quality and accuracy. The inclusion of a larger number of sentinel sites that are generalisable to the population being served would provide an accurate and region-specific system for the purposes of population health planning at the primary care level in order to improve the overall health of the community.

Conclusion
==========

This study has demonstrated that extraction of patient clinical data from general practice settings is both a feasible and valid method to obtain a region-specific estimate of the prevalence of chronic diseases and mental health disorders within regional NSW, Australia. General practices that agreed to participate were included in the study, however further sampling methodology is required to identify which sentinel sites would provide an accurate and truly representative surveillance system. Technological updates/changes to general practice clinical software systems are recommended to improve functionality and data quality within general practice databases. Drop down menus with fixed nationally recognised lists of suburb names, cross matched with correct geographical concordance postcode and state information is currently lacking within the general practice clinical software systems. Additionally, making age, sex, postcode and suburb mandatory fields for creating a new patient record could eliminate the issue of missing data for these essential socio-demographic variables. Investment in computer skills and data entry training for general practice staff and advancements in data aggregation instruments are essential to improve quality of clinical data and their collection methods for effective utilisation by researchers and population health planners for surveillance purposes. Annually obtained chronic disease prevalence figures through the surveillance methodology implemented by the SPDS project, could provide more updated and granular health information for prompt health service planning.
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